vimarsana.com

Advanced Heart Failure Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedStar Washington Hospital Center enrolls first U S patient in gene-editing therapy trial for heart disease

The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

MedStar Health Launches Participation in Phase 3 MAGNITUDE Gene-Editing Study with First U S Heart Patient Treated at MedStar Washington Hospital Center

Study examines if gene editing can help people living with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) WASHINGTON, May 2, 2024 /PRNewswire/ The.

The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.